Literature DB >> 10678630

Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD.

S R Rutgers1, W Timens, H F Kaufmann, T W van der Mark, G H Koëter, D S Postma.   

Abstract

It is unclear how cellular and soluble inflammatory markers in induced sputum relate to markers in lavage fluid and biopsies in chronic obstructive pulmonary disease (COPD). This was investigated and also the possible differences between subjects with COPD and healthy controls assessed. Eighteen nonatopic subjects with COPD and 11 healthy controls were studied. Sputum was induced by inhalation of hypertonic saline. The airways were lavaged, using the first 50 mL for bronchial wash (BW) and the subsequent 150 mL for bronchoalveolar lavage (BAL), and biopsies were taken from subsegmental carinae. Neutrophils were the predominant cell type in sputum in COPD (median 77.3%) but not in BW (5.5%) and BAL fluid (1.7%). Differential cell counts in sputum did not correlate with the counts in BW or BAL fluid or biopsies, whereas sputum eosinophil cationic protein (ECP) levels correlated with BW fluid ECP levels (p=0.66, p=0.007) and sputum interleukin-8 (IL-8) concentration with BAL fluid IL-8 concentration (p= 0.52, p=0.026). Subjects with COPD had a higher percentage of sputum neutrophils and eosinophils and higher concentrations of ECP and IL-8 than healthy controls. The higher percentages of eosinophils and concentrations of ECP were also seen in BW and BAL fluid. Finally, higher numbers of macrophages and eosinophils were found in biopsies. In conclusion, induced sputum is derived from a different compartment from BW and BAL fluid and biopsies. Induced sputum may be useful for studying the contribution of luminal neutrophils and eosinophils in chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678630     DOI: 10.1183/09031936.00.15110900

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  47 in total

Review 1.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

2.  Chemokine expression by small sputum macrophages in COPD.

Authors:  Marion Frankenberger; Christiane Eder; Thomas P J Hofer; Irene Heimbeck; Kerstin Skokann; Gudrun Kassner; Norbert Weber; Winfried Möller; Loems Ziegler-Heitbrock
Journal:  Mol Med       Date:  2011-02-09       Impact factor: 6.354

3.  Macrophages from the upper and lower human respiratory tract are metabolically distinct.

Authors:  Katelyn S Lavrich; Adam M Speen; Andrew J Ghio; Philip A Bromberg; James M Samet; Neil E Alexis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-08-09       Impact factor: 5.464

4.  Alveolar eosinophilia in current smokers with chronic obstructive pulmonary disease in the SPIROMICS cohort.

Authors:  Carlos H Martinez; Sara X Li; Andrew J Hirzel; Valerie R Stolberg; Neil E Alexis; R Graham Barr; Eugene R Bleecker; Elizabeth E Carretta; Stephanie A Christenson; Christopher B Cooper; David J Couper; Claire M Doerschuk; MeiLan K Han; Nadia N Hansel; Annette T Hastie; Eric A Hoffman; Robert J Kaner; Fernando J Martinez; Deborah A Meyers; Wanda K O'Neal; Robert Paine; Nirupama Putcha; Stephen I Rennard; Prescott G Woodruff; Michelle Zeidler; Jeffrey L Curtis; Christine M Freeman
Journal:  J Allergy Clin Immunol       Date:  2017-09-12       Impact factor: 10.793

Review 5.  Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

Authors:  K Suresh Babu; Jack A Kastelik; Jaymin B Morjaria
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

6.  Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients.

Authors:  Margaretha van der Deen; Hendrik Marks; Brigitte W M Willemse; Dirkje S Postma; Michael Müller; Egbert F Smit; George L Scheffer; Rik J Scheper; Elisabeth G E de Vries; Wim Timens
Journal:  Virchows Arch       Date:  2006-10-27       Impact factor: 4.064

7.  Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers.

Authors:  Izolde Bouloukaki; Maria Tsoumakidou; Constantine I Vardavas; Ioanna Mitrouska; Eleni Koutala; Nikolaos M Siafakas; Sophia E Schiza; Nikos Tzanakis
Journal:  Mediators Inflamm       Date:  2010-02-23       Impact factor: 4.711

8.  Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.

Authors:  Richard A Urbanowicz; Jonathan R Lamb; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  Respir Res       Date:  2010-06-11

9.  Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic tools in the challenge of distinguishing asthma and COPD phenotypes in clinical practice.

Authors:  Efrossini Dima; Nikoletta Rovina; Christina Gerassimou; Charis Roussos; Christina Gratziou
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07

Review 10.  Cough and its importance in COPD.

Authors:  Jaclyn Smith; Ashley Woodcock
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.